Alethea Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $81.5M | Buy |
|
|||||
|
2025
Q2 | $69.7M | Hold |
|
|||||
|
2025
Q1 | $77.8M | Sell |
|
|||||
|
2024
Q4 | $62.1M | Sell |
|
|||||
|
2024
Q3 | $66.4M | Sell |
|
|||||
|
2024
Q2 | $59.6M | Buy |
|
|||||
|
2024
Q1 | $59.1M | Sell |
|
|||||
|
2023
Q4 | $59.9M | Sell |
|
|||||
|
2023
Q3 | $53M | Sell |
|
|||||
|
2023
Q2 | $54.6M | Sell |
|
|||||
|
2023
Q1 | $48.5M | Hold |
|
|||||
|
2022
Q4 | $60.6M | Sell |
|
|||||
|
2022
Q3 | $35.2M | Sell |
|
|||||
|
2022
Q2 | $30.3M | Sell |
|
|||||
|
2022
Q1 | $43.2M | Sell |
|
|||||
|
2021
Q4 | $42.5M | Sell |
|
|||||
|
2021
Q3 | $37.3M | Buy |
|
|||||
|
2021
Q2 | $68.2M | Sell |
|
|||||
|
2021
Q1 | $57.3M | Buy |
|
|||||
|
2020
Q4 | $82.3M | Buy |
|
|||||
|
2020
Q3 | $71.9M | Buy |
|
|||||
|
2020
Q2 | $83M | Buy |
|
|||||
|
2020
Q1 | $58.3M | Sell |
|
|||||
|
2019
Q4 | $103M | Sell |
|
|||||
|
2019
Q3 | $26.4M | Hold |
|
|||||
|
2019
Q2 | $33.5M | Buy |
|
|||||
|
2019
Q1 | $16.2M | Buy |
|
|||||
|
2018
Q4 | $2.56M | Buy |
|
|||||
|
2018
Q3 | $1.89M | Buy |
|
|||||
|
2018
Q2 | $867K | Buy |
|
|||||
|
2018
Q1 | $285K | Hold |
|
|||||
|
2017
Q4 | $652K | Buy |
|